Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin.
about
Chronic alcohol consumption potentiates the development of diabetes through pancreatic β-cell dysfunctionNew Insights into the Pathogenesis of Alcohol-Induced ER Stress and Liver DiseasesEndoplasmic reticulum heat shock protein gp96 maintains liver homeostasis and promotes hepatocellular carcinogenesis.Alkaline ceramidase 3 deficiency aggravates colitis and colitis-associated tumorigenesis in mice by hyperactivating the innate immune system.Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences.Sphingolipids and mitochondrial function, lessons learned from yeastThe Role of Ceramide in the Pathogenesis of Alcoholic Liver Disease.Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.Myriocin prevents muscle ceramide accumulation but not muscle fiber atrophy during short-term mechanical unloading.Ccdc3: A New P63 Target Involved in Regulation Of Liver Lipid Metabolism.A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis.The role of sphingolipids in psychoactive drug use and addiction.Akt/eNOS signaling pathway mediates inhibition of endothelial progenitor cells by palmitate-induced ceramide.Ethanol and C2 ceramide activate fatty acid oxidation in human hepatoma cells
P2860
Q28082228-DF68D3C6-F944-47F7-8078-A0ADCAA09EE8Q33608283-F2C8D831-73AA-42C6-B943-6F7A6DD12700Q35204677-3B0537A1-9583-4E09-8F2F-8AA758E28070Q36774954-5DD21DB4-3BCA-48AB-85B4-26EDE4AB77CBQ37635136-79C2AAF8-CA47-416C-8BB0-5728E210B09DQ37698292-85C6CA2C-B67C-4070-A844-5EA1E724A552Q38618873-0BA04F4D-ACDB-41D3-9079-B2C85B02BDF6Q38833111-4FF2316D-3D62-4E26-84DD-31A70914CBF7Q40350492-86CF0C5F-73A3-4869-BC73-543EEEA259DCQ41483722-A9B52639-ECB1-4DC1-B783-C6AC3904D862Q47780310-127FE64A-EC29-449C-AC6F-F6FE9F50881BQ50098238-EE090D7F-B8E0-42B9-9B3E-4DF2615B3183Q54310846-D2F6E137-1BE9-4F69-A9DB-AEF26ABEB056Q58701278-766A58A3-2378-4539-B287-C8D166986FFA
P2860
Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Therapeutic reversal of chroni ...... e ceramide inhibitor myriocin.
@en
Therapeutic reversal of chroni ...... e ceramide inhibitor myriocin.
@nl
type
label
Therapeutic reversal of chroni ...... e ceramide inhibitor myriocin.
@en
Therapeutic reversal of chroni ...... e ceramide inhibitor myriocin.
@nl
prefLabel
Therapeutic reversal of chroni ...... e ceramide inhibitor myriocin.
@en
Therapeutic reversal of chroni ...... e ceramide inhibitor myriocin.
@nl
P2093
P2860
P356
P1476
Therapeutic reversal of chroni ...... e ceramide inhibitor myriocin.
@en
P2093
Jack R Wands
Lisa Longato
Suzanne M de la Monte
Teresa Ramirez
Valerie Zabala
P2860
P356
10.1111/IEP.12052
P577
2013-10-29T00:00:00Z